Mednax Inc Stock Today
| MD Stock | USD 14.22 0.15 1.07% |
Performance10 of 100
| Odds Of DistressLess than 27
|
Mednax is trading at 14.22 as of the 17th of December 2024, a 1.07 percent increase since the beginning of the trading day. The stock's lowest day price was 13.9. Mednax has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. Note, on October 29, 2018, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Mednax Inc's common stock.
Business Domain Health Care Equipment & Services | IPO Date 19th of September 1995 | Category Healthcare | Classification Health Care |
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. The company has 85.88 M outstanding shares of which 2.98 M shares are now sold short in the market by investors with about 3.51 days to cover all shorted shares. More on Mednax Inc
Moving together with Mednax Stock
Moving against Mednax Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Mednax Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | James MD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Healthcare, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsMednax can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mednax's financial leverage. It provides some insight into what part of Mednax's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mednax Inc (MD) is traded on New York Stock Exchange in USA. It is located in 1301 Concord Terrace, Sunrise, FL, United States, 33323 and employs 5,450 people. Mednax is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a market capitalization of 1.24 B. Mednax Inc is active under Health Care Providers & Services sector as part of Health Care industry. The entity has 85.88 M outstanding shares of which 2.98 M shares are now sold short in the market by investors with about 3.51 days to cover all shorted shares.
Mednax Inc reports about 9.82 M in cash with 137.32 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29.
Check Mednax Probability Of Bankruptcy
Ownership AllocationThe majority of Mednax outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mednax Inc to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mednax Inc. Please pay attention to any change in the institutional holdings of Mednax as this could imply that something significant has changed or is about to change at the company. On October 29, 2018, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Mednax Inc's common stock.
Check Mednax Ownership Details
Mednax Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Segall Bryant & Hamill | 2024-09-30 | 1.2 M | |
| Caspian Capital Partners, L.p. | 2024-09-30 | 1.1 M | |
| Citadel Advisors Llc | 2024-09-30 | 1.1 M | |
| Amvescap Plc. | 2024-09-30 | 1 M | |
| Jpmorgan Chase & Co | 2024-09-30 | 942.3 K | |
| Dana Investment Advisors Inc | 2024-09-30 | 915.6 K | |
| Weiss Asset Management Lp | 2024-09-30 | 912.8 K | |
| Goldman Sachs Group Inc | 2024-09-30 | 851.4 K | |
| Northern Trust Corp | 2024-09-30 | 818.8 K | |
| Blackrock Inc | 2024-06-30 | 13.7 M | |
| Vanguard Group Inc | 2024-09-30 | 10.7 M |
Mednax Historical Income Statement
Mednax Stock Against Markets
Mednax Corporate Directors
| Enrique Sosa | Independent Director | Profile | |
| Paul Gabos | Independent Director | Profile | |
| Pascal Goldschmidt | Independent Director | Profile | |
| Waldemar Carlo | Independent Director | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (2.40) | Revenue Per Share 24.174 | Quarterly Revenue Growth 0.009 | Return On Assets 0.0467 |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.